社区卫生工作者主导的高血压管理
评估移动临床决策支持应用程序支持的社区卫生工作者主导的高血压管理与医生护理相比的有效性和安全性:一项随机、对照、非劣效性试验
This study is to determine if hypertension management by community health workers (CHW) supported by a mobile health application and remote physician supervision is non-inferior to management by a physician for the primary outcome of improvement in systolic blood pressure. The target population is patients with hypertension in rural Guatemala. Study duration will be 12-24 months.
研究概览
地位
条件
详细说明
The investigators have developed an innovative system of care utilizing CHWs equipped with a mobile application and supported and supervised remotely by physicians. This model of care is adapted from a CHW-led diabetes program enabled by a similar CDS application which the investigators implemented in the same communities in rural Guatemala where we will carry out this proposed study. This program safely led to significant improvements in glycemic control. The mobile application is built on the widely-used CommCare platform and provides clinical decision support (CDS) to CHWs based on protocols from the WHO and the International Society of Hypertension for antihypertensive medication initiation and titration, lifestyle counseling, and identification of patients requiring a higher level of care.
The Primary Objective is to determine if hypertension management by CHWs is non-inferior to care provided directly by a physician.
The Secondary Objective is to evaluate the safety, acceptability to patients, and cost of CHW-led care compared to care provided directly by a physician.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
San Lucas Tolimán、危地马拉
- Community
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Adults age 18 or greater with diagnosis of hypertension AND blood pressure (BP) greater than or equal to 140/90 OR currently taking antihypertensive medication.
- Ability to provide informed consent
Exclusion Criteria:
- Pregnancy
- Severe comorbid condition(s) with life expectancy less than 1 year
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:医生护理
|
The physician will have received training and orientation on the same clinical protocols followed by the CHWs, as well as access to reference materials for these protocols, but the version of the CommCare application used will not provide CDS, but will serve to record and review patient data only. |
|
实验性的:Community Health Worker Care
Multimodal health systems intervention: hypertension management by trained CHWs equipped with a mobile clinical decision support (CDS) application and remote supervision and support by physicians. CHWs will meet with patients each month and, with the assistance of the CDS application, follow physician-approved and evidence-based protocols to initiate and titrate antihypertensives and medications to reduce cardiovascular risk; identify potential complications of hypertension or problems with medications; and provide lifestyle counseling. For patients with comorbid hypertension and diabetes, CHWs will also manage glycemic therapy and assess for diabetes complications with the assistance of the application. |
For those assigned to the CHW arm, management will be assisted by CDS from the CommCare application. teleconsultation with a supervising physician |
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
收缩压(SBP)变化
大体时间:基线、6个月、12个月(所有参与者评估至6个月,但早期入组参与者也可能在12、18和24个月进行评估)
|
基线、6个月、12个月(所有参与者评估至6个月,但早期入组参与者也可能在12、18和24个月进行评估)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
收缩压低于140mmHg的受试者比例
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
实现个性化目标的收缩压(SBP)低于目标的参与者比例
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期入组研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期入组研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
舒张压(DBP)变化
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期入组的参与者也可能在12个月、18个月和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期入组的参与者也可能在12个月、18个月和24个月时接受评估)
|
|
|
血红蛋白A1c(HbA1c)变化
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
体重变化
大体时间:基线、6个月、12个月(所有参与者评估至6个月,但早期入组研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者评估至6个月,但早期入组研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
总胆固醇变化
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期入组的参与者也可在12、18和24个月进行评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期入组的参与者也可在12、18和24个月进行评估)
|
|
|
LDL胆固醇变化
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但较早参与研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但较早参与研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
高密度脂蛋白胆固醇变化
大体时间:基线、6个月、12个月(所有参与者评估至6个月,但较早参与研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者评估至6个月,但较早参与研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
甘油三酯变化
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
肌酐变化
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
估计肾小球滤过率(eGFR)的变化
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期入组研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期入组研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
10年心血管疾病风险变化(根据世界卫生组织风险预测图表)
大体时间:基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
基线、6个月、12个月(所有参与者均评估至6个月,但早期参与研究的参与者也可能在12、18和24个月时接受评估)
|
|
|
Change in Diabetes Control
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
Indicated by the proportion of diabetic patients with HbA1c less than 8 and the proportion of diabetic patients with HbA1c less than their personalized goal. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in Hypertension Self-Care Activity Level Effects (H-SCALE): Medication Adherence Subscale Score
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
The H-SCALE: Medication Adherence subscale is scored from 0-21 where higher scores indicate a more positive attitude toward adherence. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in H-SCALE: Weight Management Score
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
The H-SCALE: Weight Management subscale is scored from 9-45 where higher scores indicate a more positive attitude toward weight management. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in H-SCALE: Physical Exercise Score
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
The H-SCALE: Physical Exercise subscale is scored from 0-14 where higher scores indicate a more positive behavior toward physical exercise. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in H-SCALE: Smoking Exposure Score
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
The H-SCALE: Smoking Exposure subscale is scored from 0-14 where a score of 0 indicates a more positive attitude toward smoking exposure. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in H-SCALE: Alcohol Intake Score
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
The H-SCALE: Alcohol Intake subscale contains three questions and is scored as abstainer (does not drink) or non-adherent (reported drinking alcohol). |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in H-SCALE: Healthy Eating Plan Score
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
The H-SCALE: Healthy Eating Plan subscale is scored from 0-70 where higher scores indicate a more positive attitude toward healthy eating. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in selected items from the Patient Assessment of Chronic Illness Care (PACIC) survey
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
PACIC will be scored on a likert scale from 1-5 (almost never to almost always) where higher scores indicate better assessment of chronic illness care. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in global hypertension care satisfaction score
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
Scored from 1-5 where higher scores indicate less satisfaction with hypertension care. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in pill count adherence ratio (PCAR)
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
PCAR is the total number of doses dispensed less that total doses missed divided by the total doses dispensed. |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Change in self-reported adherence
大体时间:Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
Self-reported adherence is rated on a five point scale of how often patients are taking their medications as directed, from "less than half the time" to "100% of the time". |
Baseline, 6 months, 12 months (all participants assessed to 6 months, but participants on study early may also be assessed at 12, 18 and 24 months)
|
|
Proportion of lifestyle knowledge questions answered correctly
大体时间:through study completion, an average of 12 months
|
The proportion of a set of true-false or multiple choice questions developed for this study to assess hypertension-related lifestyle knowledge answered correctly |
through study completion, an average of 12 months
|
其他结果措施
结果测量 |
大体时间 |
|---|---|
|
6 个月和 12 个月时的参与者保留率
大体时间:6个月、12个月
|
6个月、12个月
|
|
6 个月和 12 个月时完成的可能研究访问的比例
大体时间:6个月、12个月
|
6个月、12个月
|
|
研究访问的平均持续时间
大体时间:长达 24 个月
|
长达 24 个月
|
|
每次患者就诊的医生审查和护理协调时间的平均持续时间
大体时间:长达 24 个月
|
长达 24 个月
|
|
抗高血压药物处方和剂量的比较
大体时间:长达 24 个月
|
长达 24 个月
|
|
有服用阿司匹林适应症的患者比例
大体时间:长达 24 个月
|
长达 24 个月
|
|
服用两种或多种抗高血压药物的患者比例
大体时间:长达 24 个月
|
长达 24 个月
|
|
预计护理费用
大体时间:长达 24 个月
|
长达 24 个月
|
合作者和调查者
调查人员
- 首席研究员:Sean Duffy, MD、University of Wisconsin, Madison
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- 2024-0566
- A532050 (其他标识符:UW Madison)
- 4R33TW011891-03 (美国 NIH 拨款/合同)
- Protocol Version 1/12/26 (其他标识符:UW Madison)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.